UBS

Pre-open movers US stock futures are higher this morning, as investors are awaiting economic data. Futures for the Dow Jones Industrial Average surged 54 points to 12,435.00 and S&P 500 index futures rose 5.60 points to 1,314.20. Nasdaq 100 futures gained 8.25 points to 2,539.00. A Peek Into...

Pre-open movers US stock futures are higher this morning. Futures for the Dow Jones Industrial Average surged 43 points to 12,456.00 and S&P 500 index futures rose 5.20 points to 1,306.50. Nasdaq 100 futures gained 11.50 points to 2,516.25. A Peek Into Global Markets European markets were...

Pre-open movers US stock futures are mixed this morning, as investors are awaiting ISM manufacturing data. Futures for the Dow Jones Industrial Average gained 7 points to 13,162.00 and S&P 500 index futures rose 0.30 points to 1,393.90. Nasdaq 100 futures declined 1.25 points to 2,718.00. A...

UBS initiated coverage of Macy's (NYSE: M), JC Penney (NYSE: JCP), Saks (NYSE: SKS), Nordstrom (NYSE: JWN), and Kohl's (NYSE: KSS) in a research note published today. UBS initiated Nordstrom at Buy, with a $63 price target. UBS initiated Kohl's, JC Penney, Macy's, and Saks with Neutral ratings and...

Insiders may sell shares for any number of reasons, but there is really only one reason insiders buy shares of a company -- they believe the stock price will move higher and they want to profit from it. Pullbacks and sell-offs provide a perfect opportunity for investors who have faith in a company...

UBS raises its target on Neutral-rated Discovery Comm (NASDAQ: DISCA) as strong growth from Q4 continues into Q1. UBS notes, "Scatter pricing strong, cancellations in line with yr ago, and 1Q guidance for low DD U.S. ad growth. Int'l ad growth expected to remain strong despite headlines out of...

UBS raises its price target on Neutral-rated Dean Foods (NYSE: DF) to $12.50 from $11 on margin expansion. UBS says, "As expected, Dean's margins benefitted from the temporary dislocation between retail pricing and falling fluid milk input costs in 4Q11. While March milk input prices have yet to...

UBS raises its target price on Buy-rated DaVita (NYSE: DVA) to $100 from $98 as the company shifts its focus to integrated care. UBS says, "Integrated care opportunity well-vetted on call both by CEO Kent Thiry and sell-side w/ 75% of analysts asking at least one question on topic. Co remains...

UBS raises its price target on Neutral-rated Applied Materials (NASDAQ: AMAT) by 50 cents to $14 on solid momentum and order outlook for 2012. UBS notes, "Applied's Jan-12 sales/EPS exceeded the high end of its guidance. Sales upside was from its silicon division as semicap orders were up 53% q/q...